12 valve cases this week- 2MTEER, 1 VIV TMVR in a sick lady in shock, 9 TAVRs including 2 nonagenarians- one of whom was sick with complex anatomy requiring iliac lithotripsy and LMT protection, 2 sick Amyloid patients, 1 pt with creatinine 4.5; but the best of all - this 👇🏽

Thrilled to share our JACC Journals Imaging publication on physical & computational modeling for transcatheter structural interventions!
👉jacc.org/doi/10.1016/j.…

#Cardiotwitter #CardioX #EchoFirst #YesCCT #3Dprinting #TAVR #TEER #LAAO #iecho

The PREVENT trial showed that preventive #PCI of focal non-FFR-positive plaques that are angiographically >50% & have evidence of vulnerability on intravascular imaging along w/ OMT is superior to OMT for clinical outcomes at 2 years.

Read more: bit.ly/3xuHWrl

#ACC24

Dr. Isadora Sande Mathias shares insights at #ACC24 on the evolving understanding of significant functional mitral regurgitation. #MedicalResearch #Cardiology #MitralRegurgitation

So very proud of our Houston Methodist Cardiovascular Fellowships presenting their remarkable work at #ACC24 !
👏 to Yasser Sammour Sita Garapati Samarth Thakkar
#ACCFIT #Cardiotwitter

#ACC24 #DanGerShock
Allison Dupont, MD Sandeep Nathan, MD, MSc Mamas A. Mamas Dr Shariq Shamim Hady Lichaa, MD, FACC, FSCAI, FSVM, RPVI Pooja Swamy, MD, FACC, FSCAI Sanah Christopher Kashish Goel Sachin Goel Saraschandra Vallabhajosyula, MD MSc Dmitry Abramov Kate Kearney Katherine Kunkel, MD, MSEd

🆕🔎Presented at #ACC24 💡Ultrasound-assisted thrombolysis was associated w similar in-hospital mortality & bleeding complications compared w standard catheter-directed thrombolysis for acute #PE . #JSCAI

➡️doi.org/10.1016/j.jsca…

Strong work Taha Hatab Rody Bou Chaaya and team; RV PA coupling very important, nice editorial by Cleveland Clinic colleagues Christine Jellis - thank you JAHA. Samir Kapadia Ryan J Tedford MD Ashrith Guha Abbott Cardiovascular

Excited for #ACC24 ?
Visit NasirLab Houston Methodist CV prevention team presentations & share ur feedback
-Burden, variability and national/health system impact of CV metabolic risk
-CV impact of exposome measurements
- Insights on Cardiorhum & novel atheromeasurement in gen pop

👏2024 is the year to treat terrible TR #TreatTR !
#EVOQUE #TTVR & #TriClip T- #TEER have been #FDA approved, with studies demonstrating improvement in #QoL in high-risk patients with a very debilitating disease! Patient selection is🔑
#Cardiotwitter #CardioX #iecho #echofirst

Today’s news: US FDA Approval for the TriClip ! A great option for patients with severe tricuspid regurgitation! Sachin Goel Stephen Little, MD Nadeen N. Faza, M.D. Michael Reardon Houston Methodist Cardiovascular Fellowships Houston Methodist CV #CardioTwitter #Cardiology #ACC24 Abbott abbott.mediaroom.com/2024-02-13-FDA…

Well done Joe Aoun very excited and proud to have you as a partner in a few months Houston Methodist

“Steering” Toward Complete Left Atrial Appendage Closure (sciencedirect.com/science/articl…) our editorial comment on sciencedirect.com/science/articl… Sachin Goel Houston Methodist CV

Very excited to see the 2nd Edition of Cardiovascular Intervention Textbook by Dr. Deepak L. Bhatt. Thank you very much Dr Bhatt and congratulations. Samir Kapadia Joe Aoun Houston Methodist Cardiovascular Fellowships WilliamZoghbi Elsevier

Does your valve program follow the guidelines? New ACC/AHA performance (5) and quality (6) measures to evaluate your practice.
2024 ACC/AHA Clinical Performance and Quality Measures for Adults With... sciencedirect.com/science/articl… #ACCFIT
Houston Methodist Cardiovascular Fellowships Sachin Goel Nadeen N. Faza, M.D.

Heartiest congratulations Taha Hatab for his match Cleveland Clinic IM and Sahar Samimi, M.D. for her match BCM Department of Medicine - haven’t been this excited since my own match almost 2 decades ago!! So proud of our research mentees Houston Methodist WilliamZoghbi Khurram Nasir Stephen Little, MD

MTEER optimization- don’t leave behind >mild residual MR, mean gradient >5, treat MR early, before right sided valve dysfunction sets in- these are poor prognostic markers. Taha Hatab Sahar Samimi, M.D. Syed Zaid, MD Khurram Nasir WilliamZoghbi Dipan J. Shah, MD Nadeen N. Faza, M.D. Stephen Little, MD

European Society of Cardiology meta-analysis in @Eur_Heart_J examines CVD risk communication-> effective interventions
Our editorial, inspired by Harlan Krumholz aspiration 'inform but not dictate, guide but not enforce, and support but not restrict', advocates for 'getting it right'
academic.oup.com/eurheartj/adva…

Evolut TAVR is cost effective compared to SAVR- from the Master of Cost effectiveness David J. Cohen, MD, MSc CRT Meeting Paul Mahoney Ron Waksman Kendra J. Grubb M.D. Samir Kapadia megan coylewright md mph Michael Reardon Suzanne J. Baron MD MSc Medtronic Structural Heart

Really proud of our Houston Methodist Cardiovascular Fellowships and post docs for their presentations CRT Meeting #CRT2024 . Congrats team. Keep up the great work. WilliamZoghbi Stephen Little, MD Nadeen N. Faza, M.D. Valeria Duarte MD MPH Syed Zaid, MD Alpesh Shah M.D. Khurram Nasir